Asian stock markets fluctuated Wednesday after a strong start to the week as investors weighed weak US consumer data that ...

Stock markets mostly rose Tuesday as traders assessed company earnings and the outlook for the tech sector, ahead of key US economic data releases this week.

The public release improves audio, speech, debugging, and developer experience. Additionally, a more cost-effective mini variant can be used.

Speaking in front of people can make us nervous even in our first language, so it can be even worse in a foreign language because we have less control over what we’re saying. Learn from experts about ...

Elizabeth I forgot, I forget the word when I try to speak. For a moment my mind is blank. Miguel I know what I want to say, ...

Southlake Carroll ISD trustees heard a proposal Monday to close an intermediate school serving students in the fifth and sixth grades, and to reroute those students to elementary and middle schools.

Markets still anticipate easing in 2026, but only at the margins. Recent reporting from Bloomberg and Reuters suggests growing interest in five-year Treasuries, reflecting concern that longer-dated ...

With long end yields elevated, fixed income remains attractive across multiple segments. Rate cuts, corporate earnings, and stable credit markets are supportive to Vanguard’s VGHY and VCIT. With the ...

For investors seeking higher yields than what intermediate core bonds can provide, the next step up the risk ladder are funds in the Morningstar intermediate core-plus bond category. To screen for the ...

The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...

Large-bore mechanical thrombectomy (LBMT) was superior to catheter-directed thrombolysis (CDT) for treatment of intermediate-risk pulmonary embolism (PE), based on data from 550 individuals presented ...

Irreversible electroporation using the NanoKnife System provided effective focal therapy option for intermediate-risk prostate cancer, with mostly favorable oncologic and functional outcomes. For ...